160 related articles for article (PubMed ID: 16736177)
1. [Pitfalls in the classification of liver tumors].
Wittekind C
Pathologe; 2006 Jul; 27(4):289-93. PubMed ID: 16736177
[TBL] [Abstract][Full Text] [Related]
2. [Histological classification of hepatocellular carcinoma].
Kojiro M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
[No Abstract] [Full Text] [Related]
3. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
[TBL] [Abstract][Full Text] [Related]
4. [Liver cancer: diagnostic possibilities and value of pathology].
Wittekind C
Zentralbl Chir; 1994; 119(11):753-8. PubMed ID: 7846954
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: pathology and liver biopsy.
Kalinski T; Roessner A
Dig Dis; 2009; 27(2):102-8. PubMed ID: 19546547
[TBL] [Abstract][Full Text] [Related]
6. Obstructions of portal veins and tumor numbers are associated with humped hepatocellular carcinoma.
Sanomura T; Ikeda F; Katoh T; Hosokawa K; Suzuki S; Nishiyama Y
Acta Med Okayama; 2010 Oct; 64(5):299-305. PubMed ID: 20975763
[TBL] [Abstract][Full Text] [Related]
7. [Regulations in the classification of primary liver neoplasms].
Kasai Y; Sugahara K
Nihon Rinsho; 1982; 40(1):15-25. PubMed ID: 6283200
[No Abstract] [Full Text] [Related]
8. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan.
Kee KM; Wang JH; Lee CM; Chen CL; Changchien CS; Hu TH; Cheng YF; Hsu HC; Wang CC; Chen TY; Lin CY; Lu SN
Int J Cancer; 2007 Jun; 120(12):2650-5. PubMed ID: 17304512
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
10. Staging for hepatocellular carcinoma: look for a perfect classification system.
Huo TI; Lee SD; Wu JC
J Hepatol; 2004 Jun; 40(6):1041-2; author reply 1042-3. PubMed ID: 15158351
[No Abstract] [Full Text] [Related]
11. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
12. Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.
Addissie BD; Roberts LR
Clin Liver Dis; 2015 May; 19(2):277-94. PubMed ID: 25921663
[TBL] [Abstract][Full Text] [Related]
13. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.
Sumie S; Nakashima O; Okuda K; Kuromatsu R; Kawaguchi A; Nakano M; Satani M; Yamada S; Okamura S; Hori M; Kakuma T; Torimura T; Sata M
Ann Surg Oncol; 2014 Mar; 21(3):1002-9. PubMed ID: 24254204
[TBL] [Abstract][Full Text] [Related]
14. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and differential diagnosis of hepatocellular carcinoma].
Drebber U; Dienes HP
Pathologe; 2006 Jul; 27(4):294-9. PubMed ID: 16767425
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Liver Tumors: Updates in Classification.
Cho SJ
Surg Pathol Clin; 2020 Dec; 13(4):601-623. PubMed ID: 33183723
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.
Colecchia A; Scaioli E; Montrone L; Vestito A; Di Biase AR; Pieri M; D'Errico-Grigioni A; Bacchi-Reggiani ML; Ravaioli M; Grazi GL; Festi D
J Hepatol; 2011 Feb; 54(2):300-5. PubMed ID: 21056498
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
